Detalles de la búsqueda
1.
Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Eur J Haematol
; 101(1): 95-105, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660177
2.
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(4): 495-500, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374213
3.
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
Lancet Haematol
; 11(6): e406-e414, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796193
4.
Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma.
Int J Hematol
; 117(5): 729-737, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690910
5.
Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation.
Support Care Cancer
; 20(2): 367-73, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21328006
6.
A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
Support Care Cancer
; 20(5): 933-9, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21494780
7.
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment.
Int J Hematol
; 116(1): 122-130, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429329
8.
DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma.
Biochem Biophys Res Commun
; 395(1): 111-5, 2010 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350533
9.
Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.
Am J Hematol
; 85(4): 243-8, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20162540
10.
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant
; 15(6): 679-85, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450752
11.
Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Biol Blood Marrow Transplant
; 15(6): 724-9, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450757
12.
Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
J Med Virol
; 81(6): 979-82, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19382259
13.
FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
Eur J Haematol
; 82(2): 143-7, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19018870
14.
[Case Report; Primary central nervous system lymphoma mimicking progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome].
Nihon Naika Gakkai Zasshi
; 103(10): 2578-80, 2014 Oct 10.
Artículo
en Japonés
| MEDLINE | ID: mdl-27514208
15.
A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
Biol Blood Marrow Transplant
; 14(7): 817-23, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18541202
16.
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 14(5): 568-75, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18410899
17.
Skin involvement in ALK-negative systemic anaplastic large-cell lymphoma.
J Am Acad Dermatol
; 67(4): e159-60, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22980280
18.
Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.
Exp Hematol
; 30(11): 1238-47, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12423676
19.
Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease.
Ann Hematol
; 86(2): 155-7, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17061101
20.
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Int J Hematol
; 96(6): 748-57, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23111539